711 results on '"Hasford, J."'
Search Results
2. Seasonal changes in prescribing of long-acting beta-2-agonists-containing drugs
3. Treatment and outcome of 2904 CML patients from the EUTOS population-based registry
4. A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction
5. Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia
6. In-hospital fall-risk screening in 4,735 geriatric patients from the LUCAS project
7. Begriffsbestimmungen
8. Methoden
9. Forschungsziele
10. Arzneimittelforschung Nach der Zulassung
11. Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
12. The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries
13. Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV
14. Quantitative Assessment of the Impact of Interferon Alpha (IFN) vs. Busulfan vs. Hydroxyurea and of Risk Profile on Survival in Chronic Myelogenous Leukemia (CML)
15. Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib
16. Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
17. Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment
18. Perspektiven
19. Inconsistent trial assessments by the National Institute for Health and Clinical Excellence and IQWiG: standards for the performance and interpretation of subgroup analyses are needed
20. Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study
21. Die Longitudinal-Urban-Cohort-Ageing-Studie (LUCAS)
22. Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemia
23. The LUCAS* consortium: Objectives of interdisciplinary research on selected aspects of ageing and health care for older people in an urban community
24. Therapie der chronischen myeloischen Leukämie bei älteren Patienten
25. LONG-ACTING BETA-2-ADRENOCEPTOR AGONISTS AND ANTICHOLINERGIC DRUGS: DRUG UTILISATION AND OFF-LABEL USE IN PAEDIATRIC PATIENTS LIVING IN BAVARIA (GERMANY): 239
26. CHANGES IN DRUG PRESCRIPTIONS AFTER THE SMART TRIAL - SECONDARY DATA ANALYSIS OF BAVARIAN ASTHMA PATIENTS: 197
27. ADRS LEADING TO HOSPITALISATION CAUSED BY SELFMEDICATION - RESULTS FROM A GERMAN LONG-TERM, OBSERVATIONAL STUDY: 178
28. Arzneimittelprüfung an nicht einwilligungsfähigen Erwachsenen: Kritische Bewertung der neuen gesetzlichen Regelung durch medizinische Ethikkommissionen in Deutschland [Critical evaluation of the new legal regulation of pharmaceutical trials with adults who lack decision-making capacity: a survey of human research ethics committees in Germany]
29. Psychopharmakologische Behandlungspraxis in Münchener Altenpflegeheimen
30. Cytogenetic response to prior treatment with interferon-α is predictive for survival after allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia
31. Gender aspects in chronic myeloid leukemia: long-term results from randomized studies
32. Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response: meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia
33. The German competence network ‘Acute and chronic leukemias’
34. Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia – prospective long-term results from a randomized-controlled trial
35. Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon α
36. Randomized comparison of interferon α and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon α and hydroxyurea
37. Design and implementation of a common drug information database for a university hospital
38. German Multicenter Study Group for Adult ALL (GMALL): recruitment in comparison to ALL incidence and its impact on study results
39. Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis
40. A population-based European cohort study of persistence in newly diagnosed hypertensive patients
41. Wissensstand und Einstellungen der Allgemeinbevölkerung zu Symptomen, Ursachen und Behandlungsmöglichkeiten depressiver Erkrankungen
42. Einleitung
43. Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
44. Data from the German-Austrian-Suisse MDS registry (D-A-CH MDS registry): V954
45. 12 month molecular response < 1% BCR-ABL (IS) is associated with improved overall and progression-free survival in CML patients: V635
46. Superior CMR-rates with tolerability-adapted imatinib 800 mg vs. 400 mg vs. 400 mg + IFN in CML: The randomized German CML-Study IV: V633
47. Therapy with imatinib in elderly CML patients (≥65 years): Results of the German CML-Study IV: V632
48. Coping with the new statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemia: V636
49. Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany
50. Confirmation of the mantle cell lymphoma international prognostic index (MIPI) in an independent prospective cohort: V679
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.